Skip to main content
Shun Yu, MD, Oncology, New York, NY

Shun Yu MD


Oncology Attending Physician

Join to View Full Profile
  • 160 E 34th StNew York, NY 10016

  • Phone+1 212-731-6120

Dr. Yu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2018 - 2021
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2014
  • Columbia University in the City of New York
    Columbia University in the City of New YorkBiomedical Engineering, Summa Cum Laude, 2005 - 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2021 - 2026
  • PA State Medical License
    PA State Medical License 2014 - 2021
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma  
    Shun Yu, Deyali Chatterjee, Rong Ye, Prajnan Das, Naveen Garg, Robert A Wolff, Huamin Wang, Eugene J Koay, Gauri R Varadhachary, Christopher H Crane, Milind Javle, Jef..., Clinical Cancer Research

Press Mentions

  • Gastrointestinal Chemotherapy Tweak Can Reduce Side Effects
    Gastrointestinal Chemotherapy Tweak Can Reduce Side EffectsSeptember 6th, 2024
  • Study Backs Skipping 5-FU Bolus in Chemo Regimens for Gastrointestinal Cancers
    Study Backs Skipping 5-FU Bolus in Chemo Regimens for Gastrointestinal CancersSeptember 5th, 2024
  • New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal Cancers
    New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal CancersSeptember 5th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: